A Type 1 approach to Type 2 diabetes? A pilot study comparing traditional twice-daily insulin with basal bolus and carbohydrate counting regimens

被引：0
|
作者：
Charlton, J.
Kilbride, L.
Mackay, L.
Douglas, S.
McKnight, J.
机构：
[1] Western Gen Hosp, Metab Unit, Edinburgh EH4 2XU, Midlothian, Scotland
[2] Napier Univ, Sch Nursing, Edinburgh EH14 1DJ, Midlothian, Scotland
来源：
DIABETIC MEDICINE | 2007年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [41] Basal Plus Basal-Bolus Approach in Type 2 Diabetes
    Javier Ampudia-Blasco, F.
    Rossetti, Paolo
    Ascaso, Juan F.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 : S - 75
  • [42] Intensification of IDegAsp Twice Daily (Adding Insulin Aspart vs. Switching To Basal–Bolus): Exploratory Randomized Trial in Type 2 Diabetes
    Wan Mohamaed Wan Bebakar
    Louis Chaykin
    Malene Lundgren Hersløv
    Søren Rasmussen
    Diabetes Therapy, 2017, 8 : 197 - 205
  • [43] The PREFER study:: both biphasic insulin aspart 30 twice-daily and basal-bolus using insulin detemir and insulin aspart enabled patients with type 2 diabetes to achieve HbA1c target<7.0%
    Liebl, A.
    Prager, R.
    Kaiser, M.
    Binz, K.
    Gailwitz, B.
    DIABETOLOGIA, 2006, 49 : 610 - 611
  • [44] Increased insulinization with once-dailyas compared to twice-daily insulin glargine in type 1 diabetes.
    Schroeder, E
    Clark, CD
    Burge, MR
    JOURNAL OF INVESTIGATIVE MEDICINE, 2004, 52 (01) : S86 - S86
  • [45] Comparing the effects of twice-daily exenatide and insulin on renal function in patients with type 2 diabetes mellitus: secondary analysis of a randomized controlled trial
    Zhang, Jie
    Xian, Tong-Zhang
    Wu, Ming-Xiao
    Li, Chen
    Wang, Weihao
    Man, Fuli
    Zhang, Xianbo
    Wang, Xiaoxia
    Pan, Qi
    Guo, Lixin
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (07) : 1529 - 1535
  • [46] Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart
    Ashwell, S. G.
    Gebbie, J.
    Home, P. D.
    DIABETIC MEDICINE, 2006, 23 (08) : 879 - 886
  • [47] Twice-daily compared with once-daily insulin glargine in people with type 1 diabetes using meal-time insulin aspart
    Ashwell, SG
    Gebbie, J
    Home, PD
    DIABETES, 2005, 54 : A119 - A119
  • [48] Effect of switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL (Gla-300) in Brazilian people with type 1 diabetes
    Dualib, Patricia Medici
    Dib, Sergio Atala
    Augusto, Gustavo Akerman
    Truzzi, Ana Cristina
    de Paula, Mauricio Aguiar
    Rea, Rosangela Roginski
    DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01):
  • [49] Comparison of twice-daily injections of biphasic insulin lispro and basal-bolus therapy: glycaemic control and quality-of-life of insulin-naive type 2 diabetic patients
    Masuda, H.
    Sakamoto, M.
    Irie, J.
    Kitaoka, A.
    Shiono, K.
    Inoue, G.
    Atsuda, K.
    Yamada, S.
    DIABETES OBESITY & METABOLISM, 2008, 10 (12): : 1261 - 1265
  • [50] Intensification of IDegAsp Twice Daily (Adding Insulin Aspart vs. Switching To Basal-Bolus): Exploratory Randomized Trial in Type 2 Diabetes
    Bebakar, Wan Mohamaed Wan
    Chaykin, Louis
    Herslov, Malene Lundgren
    Rasmussen, Soren
    DIABETES THERAPY, 2017, 8 (01) : 197 - 205
12345